Renal Cancer - Results from #280

REVIEW UroToday

A phase II trial of intrapatient dose-escalated sorafenib in patients with metastatic renal cell carcinoma, "Beyond the Abstract," by Robert J. Amato, DO January 25, 2013

Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC), "Beyond the Abstract," by Jonathan L Silberstein, MD and Paul Russo, MD, FACS January 25, 2013

VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma, "Beyond the Abstract," by Nicholas G. Cost, MD and Maria F. Czyzyk-Krzeska, MD, PhD January 21, 2013

Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus, "Beyond the Abstract," by Philippe E. Spiess, MD, MSc, FACS, FRCS(C) January 9, 2013

Renal angiomyoadenomatous tumor: A case report and a brief review of the literature, "Beyond the Abstract," by Charanjeet Singh, MD, J. Carlos Manivel, MD, and Stefan E. Pambuccian, MD December 21, 2012

Can the Kattan nomogram still accurately predict prognosis in renal cell carcinoma using the revised 2010 tumor-nodes-metastasis reclassification? "Beyond the Abstract," by Rajan Veeratterapillay, SpR (Urol) and Rakesh Heer, PhD, F.R.C.S. (Urol) December 10, 2012

CXCR7: A novel tumor endothelial marker in renal cell carcinoma, "Beyond the Abstract," by Kyoko Hida, DDSc, PhD, et al December 5, 2012

Renal pelviceal keratinizing squamous metaplasia with sparing of pyramidal zones, "Beyond the Abstract," by Richard H. Siderits, MD and Noah S. Rolleri, MS-IV November 26, 2012

Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome, "Beyond the Abstract," by Steven C. Campbell, MD, PhD, et al. November 14, 2012

Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy, "Beyond the Abstract," by Philippe E. Spiess, MD, MSc, FACS, FRCS(C) October 26, 2012

A comprehensive overview of targeted therapy in metastatic renal cell carcinoma, "Beyond the Abstract," by Zsuzsanna Mihály, MD and Balázs Győrffy, MD, PhD, MSc October 17, 2012

Common and less-common renal masses and masslike conditions, "Beyond the Abstract," by Marinos Kontzialis, MD, et al October 9, 2012

Evaluation of perirenal fat as a predictor of cT(1a) renal cortical neoplasm histopathology and surgical outcomes, "Beyond the Abstract," by Zhamshid Okhunov, MD and Jaime Landman, MD September 25, 2012

Beyond the Abstract - Usefulness of new schemes to group Fuhrman grades in clinical practice for clear cell renal tumour, by Eduardo Morán Pascual August 17, 2012

Beyond the Abstract - Downsizing a thrombus of advanced renal cell carcinoma in a presurgical setting with sorafenib, by Hirokazu Takeda, MD August 8, 2012

Beyond the Abstract - New insights into molecular mechanisms of sunitinib-associated side effects, by Luis Antón-Aparicio and Luis Leon Mateos August 3, 2012

Beyond the Abstract - Metastatic renal cell carcinoma to the phalanx, by Douglas F. Beach, MD and Robert Somer, MD July 31, 2012

Beyond the Abstract - Validation of the 2009 TNM classification for renal cell carcinoma: Comparison with the 2002 TNM classification by concordance index, by Dalsan You, MD, PhD; Chunwoo Lee, MD; and Choung-Soo Kim, MD, PhD July 13, 2012

Beyond the Abstract - Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass, by Daniel Canter, Alexander Kutikov, and Robert G. Uzzo June 29, 2012

Beyond the Abstract - Surgical management of large renal tumors, by Srinivas Vourganti, Brian Shuch, and Gennady Bratslavsky June 27, 2012

Page 15 of 16